GRIA4 Protéine

N° du produit ABIN6123136

Détail du produit

Antigène: GRIA4 (Glutamate Receptor, Ionotropic, AMPA 4 (GRIA4))

Type de proteíne: Recombinant

Origine: Humain

Source: Escherichia coli (E. coli)

Application: Western Blotting (WB), SDS-PAGE (SDS)

Attributs du produit: Human Glutamate Receptor, Ionotropic, AMPA 4 (GRIA4) Protein

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Please note that the majority of this suppliers proteins are partial length rather than full length.
We recommend customers to inquire.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Prior to lyophilization: PBS,  pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin-300.

Agent conservateur: Dithiothreitol (DTT), ProClin

Précaution d'utilisation: This product contains ProClin and Dithiothreitol (DTT): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Stock: 4 °C,-80 °C

Stockage commentaire: Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.

Détail du antigène

Antigène: GRIA4 (Glutamate Receptor, Ionotropic, AMPA 4 (GRIA4))

Autre désignation: Glutamate Receptor, Ionotropic, AMPA 4 (GRIA4 Produits)

Synonymes: GLUR4 Protein, GLUR4C Protein, GLURD Protein, GluA4 Protein, GluR4 Protein, GluR4d Protein, GLUR4/D Protein, glur4 Protein, GluR-D Protein, Glur-4 Protein, Glur4 Protein, Gluralpha4 Protein, spkw1 Protein, DKFZp459P0616 Protein, glur4a Protein, gria4 Protein, iGluR4 Protein, ZfGluR4b Protein, fj46g06 Protein, glur4b Protein, wu:fj46g06 Protein, glutamate ionotropic receptor AMPA type subunit 4 Protein, glutamate receptor, ionotropic, AMPA 4 Protein, glutamate receptor, ionotropic, AMPA4 (alpha 4) Protein, glutamate receptor, ionotropic, AMPA 4a Protein, glutamate receptor, ionotropic, AMPA 4b Protein, GRIA4 Protein, gria4 Protein, Gria4 Protein, gria4a Protein, gria4b Protein

Pathways: Signalisation PI3K-Akt